Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$125K Sell
630
-565
-47% -$103K ﹤0.01% 317
2023
Q4
$208K Buy
1,195
+80
+7% +$12.7K 0.01% 260
2023
Q3
$174K Hold
1,115
0.01% 273
2023
Q2
$183K Sell
1,115
-84
-7% -$12.3K 0.01% 280
2023
Q1
$185K Sell
1,199
-97
-7% -$15.4K 0.01% 280
2022
Q4
$171K Sell
1,296
-228
-15% -$31K 0.01% 301
2022
Q3
$163K Sell
1,524
-340
-18% -$42.7K 0.01% 300
2022
Q2
$195K Buy
1,864
+1,260
+209% +$171K 0.01% 293
2022
Q1
$90K Buy
604
+144
+31% +$17.7K ﹤0.01% 443
2021
Q4
$53K Buy
+460
New +$50.3K ﹤0.01% 516

Other funds holding NUE

Cambridge Trust's NUE Position: Q1 2024 in Review

Cambridge Trust reduced its Nucor (NUE) stake by 47% in Q1 2024, selling an estimated $103K and leaving 630 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #317.

Cambridge Trust first reported a position in NUE in Q4 2021 and has held it in 10 quarters since. The position peaked at $208K in Q4 2023. 1,294 funds tracked by Wall St. Rank hold NUE as of Q1 2024.

  • Cambridge Trust held 630 shares of Nucor worth $125K as of Q1 2024.
  • Cambridge Trust sold 565 Nucor shares in Q1 2024, an estimated $103K.
  • Nucor made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #317 holding.
  • Cambridge Trust first reported a position in Nucor in Q4 2021 and has held it in 10 quarters since.
  • Cambridge Trust's Nucor position peaked at $208K in Q4 2023.
  • 1,294 funds tracked by Wall St. Rank held Nucor as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.